Glucagon-Like Peptide-1 Agonist Exendin-4 Leads to Reduction of Weight and Caloric Intake in a Rat Model of Hypothalamic Obesity

Publisher： Karger

E-ISSN： 1663-2826|78|1|47-53

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.78, Iss.1, 2012-07, pp. : 47-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment with Glucagon-Like Peptide-1 Agonist Exendin-4 in a Patient with Hypothalamic Obesity Secondary to Intracranial Tumor

By  

Hormone Research in Paediatrics, Vol. 78, Iss. 1, 2012-07 ,pp. : 54-58

Karger

Access to resources Recommend Favorite

Mechanisms Involved in Glucagon-Like Peptide-1 (7–36) Amide Action on the Rat Hypothalamo-Neurohypophysial System

By  

Neuroendocrinology, Vol. 77, Iss. 2, 2003-03 ,pp. : 119-124

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Transactivation Is Necessary for Glucagon-Like Peptide-1 to Protect PC12 Cells from Apoptosis

By  

Neuroendocrinology, Vol. 97, Iss. 4, 2012-12 ,pp. : 300-308

Karger

Access to resources Recommend Favorite

Effects of Glucagon-Like Peptide 1 (7–36 Amide) on Glucose Kinetics during Somatostatin-Induced Suppression of Insulin Secretion in Healthy Men

By  

Hormone Research in Paediatrics, Vol. 49, Iss. 5, 1998-04 ,pp. : 221-225

Karger

Access to resources Recommend Favorite

Delta-Like 1 Homologue (DLK1) Protein in Neurons of the Arcuate Nucleus That Control Weight Homeostasis and Effect of Fasting on Hypothalamic DLK1 mRNA

By  

Neuroendocrinology, Vol. 100, Iss. 2-3, 2014-10 ,pp. : 209-220

Karger

Access to resources Recommend Favorite